Is Henry Schein (HSIC) Undervalued Following Its $1.25 Billion Credit Facility Reset?
Henry Schein’s Expanded Credit Facility Resets the Financing Picture
Henry Schein (HSIC) has reworked its revolving credit facility, lifting total commitments to $1.25 billion and extending the maturity to September 19, 2031. This move reshapes the company’s financing capacity.
Recent trading shows a mixed picture for Henry Schein. The 1 month share price return is down 3.9%. However, the year to date share price return is up 11.9%, and the 1 year total shareholder return of 30.2% points to momentum building over a longer stretch as investors digest the larger credit facility and prior guidance updates.
Scan other healthcare distributors and service providers showing similar balance sheet strength and credit firepower through our curated list of list of solid balance sheet and fundamentals (25 results)
Henry Schein now trades below both analyst targets and an internal fair value range. The question is whether that gap reflects opportunity, or represents a realistic reset in expectations.
Most Popular Narrative: 12% Undervalued
Against the last close of $85.99, the most followed narrative pegs Henry Schein’s fair value at $98.19, implying a valuation gap that hinges on execution of its margin plan.
The company is experiencing strong growth in high-margin businesses such as Specialty Products, Technology, and private-label offerings. It expects over 50% of non-GAAP operating income to come from these segments, supporting structurally higher gross margins and likely driving earnings expansion.
See why 6 investors see Henry Schein as 12% undervalued.
Result: Fair Value of $98.19 (UNDERVALUED)
Still, the Henry Schein story can unravel if scanner pricing pressure squeezes equipment margins or if multi year analyst forecasts simply prove too optimistic.
Find out about the key risks to this Henry Schein narrative.
Next Steps
Mixed signals around Henry Schein’s valuation and risk profile can feel confusing, so move quickly, review the data yourself, and weigh both sides of the story using the 2 key rewards and 1 important warning sign.
Looking for more Henry Schein style investment ideas?
Do not stop with Henry Schein. Broaden your watchlist with other targeted ideas that match your risk appetite and income goals using the Simply Wall Street Screener.
- Hunt for mispriced quality by reviewing companies highlighted in the 32 high quality undervalued stocks that pair robust fundamentals with appealing entry prices.
- Strengthen income potential by scanning the 6 dividend fortresses for businesses offering higher-yield payouts with staying power.
- Dial down volatility by focusing on the 30 resilient stocks with low risk scores and pinpointing stocks that score well on balance sheet resilience and risk checks.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com